Translational Biomarkers in Aging and Dementia (TRIAD) cohort
Biomarker oriented cohort
The TRIAD cohort was designed for two purposes, explains Pedro Rosa-Neto, associate professor in the neurology and neurosurgery and psychiatry departments. “One is to understand disease pathophysiology and the other is using the gold standard technology—PET scans—for benchmarking novel blood biomarkers. That’s what makes our cohort really special and unique.
Visit website: https://www.researchgate.net/publication/336663848_THE_TRANSLATIONAL_BIOMARKERS_IN_AGING_AND_DEMENTIA_TRIAD_A_BIOMARKER_ORIENTED_COHORT
See also: Alzheimer's & Dementia: Journal of the Alzheimer's Association - The journal publishes study results related to dementia and Alzheimer's Disease
Details last updated 25-May-2020
Translational Biomarkers in Aging and Dementia (TRIAD) cohort News
Simple blood testing to detect Alzheimer's disease
Futurity - 12-May-2020
This discovery could greatly reduce costs of diagnosing and studying the disease
Read more...